Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD

PHASE2CompletedINTERVENTIONAL
Enrollment

157

Participants

Timeline

Start Date

August 31, 2007

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions
Macular Degeneration
Interventions
DRUG

VEGF Trap Eye

Intravitreal injection

Trial Locations (33)

11563

Lynbrook

21287

Baltimore

21740

Hagerstown

28210

Charlotte

29169

West Columbia

30909

Augusta

33880

Winter Haven

33912

Fort Myers

34994

Stuart

37203

Nashville

47280

Indianapolis

57701

Rapid City

60026

Glenview

73104

Oklahoma City

76102

Fort Worth

77030

Houston

78240

San Antonio

78503

McAllen

78705

Austin

84107

Salt Lake City

85020

Phoenix

85381

Peoria

85704

Tucson

90211

Beverly Hills

91105

Pasadena

91361

Westlake Village

92064

Poway

92262

Palm Springs

92354

Loma Linda

97210

Portland

02114

Boston

01089

West Springfield

08755

Toms River

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Bayer

INDUSTRY

lead

Regeneron Pharmaceuticals

INDUSTRY